Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles

NCT02269241 is registered in ClinicalTrials.gov with Laboratories Leon Farma, S.A. as lead sponsor.

NCT NCT02269241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02269241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles
Lead sponsor
Laboratories Leon Farma, S.A.
Phase
Phase 3
Overall status
Completed
Start date
October 9, 2014
Completion date
October 4, 2017
Enrollment
1,552 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

contraception